Placebo
218MS304
Phase 3 small_molecule completed
Quick answer
Placebo for Multiple Sclerosis, Remittent Progressive is a Phase 3 program (small_molecule) at Biogen with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Biogen
- Indication
- Multiple Sclerosis, Remittent Progressive
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed